Charles Schwab’s Sharecare, Inc. Class A Common Stock SHCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,775,730
Closed -$2.52M 3545
2024
Q3
$2.52M Buy
1,775,730
+26,756
+2% +$37.1K ﹤0.01% 2641
2024
Q2
$2.36M Sell
1,748,974
-705,826
-29% -$580K ﹤0.01% 2654
2024
Q1
$1.88M Buy
2,454,800
+208,417
+9% +$209K ﹤0.01% 2606
2023
Q4
$2.43M Buy
2,246,383
+14,429
+0.6% +$14.8K ﹤0.01% 2553
2023
Q3
$2.1M Sell
2,231,954
-143,400
-6% -$171K ﹤0.01% 2580
2023
Q2
$4.16M Buy
2,375,354
+51,935
+2% +$81.4K ﹤0.01% 2308
2023
Q1
$3.3M Buy
2,323,419
+3,496
+0.2% +$7.92K ﹤0.01% 2377
2022
Q4
$3.71M Buy
2,319,923
+62,202
+3% +$115K ﹤0.01% 2357
2022
Q3
$4.29M Buy
2,257,721
+668,362
+42% +$1.17M ﹤0.01% 2294
2022
Q2
$2.51M Buy
1,589,359
+134,967
+9% +$331K ﹤0.01% 2497
2022
Q1
$3.59M Buy
1,454,392
+49,081
+3% +$161K ﹤0.01% 2434
2021
Q4
$6.31M Buy
1,405,311
+37,676
+3% +$242K ﹤0.01% 2234
2021
Q3
$11.3M Buy
+1,367,635
New +$10.3M ﹤0.01% 1938

Other funds holding SHCR

Charles Schwab's SHCR Position: Q4 2024 in Review

Charles Schwab sold out of Sharecare, Inc. Class A Common Stock (SHCR) in Q4 2024, closing a stake of 1,775,730 shares — an estimated $2.52M sold.

Charles Schwab first reported a position in SHCR in Q3 2021 and held it in 13 quarters. The position peaked at $11.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds SHCR as of Q4 2024.

  • Charles Schwab reported no remaining Sharecare, Inc. Class A Common Stock position as of Q4 2024 after selling out during the quarter.
  • Charles Schwab sold 1,775,730 Sharecare, Inc. Class A Common Stock shares in Q4 2024, an estimated $2.52M.
  • Charles Schwab first reported a position in Sharecare, Inc. Class A Common Stock in Q3 2021 and held it in 13 quarters.
  • Charles Schwab's Sharecare, Inc. Class A Common Stock position peaked at $11.3M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Sharecare, Inc. Class A Common Stock as of Q4 2024.

Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.